BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16768055)

  • 1. [Prognostic factors of ovarian cancer].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2006 May; 71(3):252-9. PubMed ID: 16768055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic aspects of malignant epithelial ovarian tumours].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2005 Jul; 70(4):299-306. PubMed ID: 16128132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
    Spacek J; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors].
    Jancárková N; Krkavcová M; Janashia M; Freitag P; Dusková J; Cibula D
    Ceska Gynekol; 2008 Apr; 73(2):79-86. PubMed ID: 18567425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics and its importance for gynecological oncology].
    Lacheta J; Cibula D; Freitag P; Zivný J
    Ceska Gynekol; 2004 Sep; 69(5):384-7. PubMed ID: 15587895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis].
    Zikán M; Pinkavová I; Sláma J; Freitag P; Janousek M; Fischerová D; Pavlista D; Cibula D
    Ceska Gynekol; 2009 Dec; 74(6):427-30. PubMed ID: 21246790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment and prognostic factors of epithelial ovarian carcinoma].
    Wang SL
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):86-8, 124. PubMed ID: 1650311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of mesenchymal and mixed tumors of uterus].
    Spacek J; Laco J; Petera J; Jílek P; Krepinská E; Rezác A; Stipl S
    Ceska Gynekol; 2009 Aug; 74(4):292-7. PubMed ID: 20564985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular prognostic factors and pathogenesis of endometrial cancer].
    Mícková I; Pilka R; L'ubuský M; Kudela M
    Ceska Gynekol; 2006 Jul; 71(4):355-60. PubMed ID: 16956055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current classification of malignant tumours in gynecological oncology--part II].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument.
    Elit LM; Levine MN; Gafni A; Whelan TJ; Doig G; Streiner DL; Rosen B
    Gynecol Oncol; 1996 Sep; 62(3):329-35. PubMed ID: 8812525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in patients with stage I epithelial ovarian cancer].
    Wen HW; Liu SW
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):235-7, 255. PubMed ID: 8082450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active cellular immunotherapy of ovarian cancer using dendritic cells].
    Brtnicky T; Podrazil M; Bartunkova J; Spíšek R; Rob L
    Ceska Gynekol; 2012 Jun; 77(3):215-20. PubMed ID: 22779721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.
    Szajnik M; Czystowska-Kuźmicz M; Elishaev E; Whiteside TL
    Expert Rev Mol Diagn; 2016 Aug; 16(8):811-26. PubMed ID: 27268121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current classification of malignant tumours in gynecological oncology--part I].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic prognostic factors in ovarian cancer: a review.
    Framarino dei Malatesta ML; Veneziano M; Peppicelli M; Lanzi G; Marzetti L
    Eur J Gynaecol Oncol; 1998; 19(2):123-5. PubMed ID: 9611049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.